A multidisciplinary approach is recommended for clinical management from infancy up to adulthood. Hormone replacement<unk>  is needed following gonadectomy. Patients who have decided to retain their gonads are considered to be at risk for developing germ cell tumors and for these the sensitive circulating tumor markers may become available soon.
Androgen insensitivity syndrome medical therapy
Turner syndrome medical therapy
Androgen insensitivity syndrome primary prevention
Androgen insensitivity syndrome secondary prevention
Hypogonadism medical therapy
17-beta-hydroxysteroid dehydrogenase deficiency medical therapy
Prolactinoma medical therapy
Adiposogenital dystrophy medical therapy